A review of more than a decade's worth of research on osteonecrosis of the jaw—when the bone in the jaw is exposed and begins to starve from a lack of blood—points to an increased risk for patients taking certain drugs ...
Dec 15, 2014
0
1
Biotech drugmaker Amgen is reportedly close to buying cancer drug maker Onyx Pharmaceuticals for about $10.5 billion.
Aug 25, 2013
0
0
Amgen Inc. said Tuesday that its second-quarter profit dipped 1 percent as higher spending on research, production and other items offset rising sales of its medicines.
Jul 30, 2013
0
0
The International Osteoporosis Foundation (IOF) has published practical guidelines to assist clinicians in assessing treatment efficacy in patients who experience a fracture while on medication for osteoporosis.
Aug 31, 2012
1
0
